Page 137 - Škrgat, Sabina, ed. 2022. Severe Asthma - Basic and Clinical Views. Koper: University of Primorska Press. Severe Asthma Forum, 1
P. 137
Popović-Grle S, Lampalo M, Škrin- 4;6(5):e18574. doi: 10.1371/journal. 137
jarić Cincar S, et al. Attitudes of Cro- pone.0018574.
atian pulmonologists concerning ob- 33. https://www.euro.who.int/en controversies and dilemmas in severe asthma
stacles to earlier, more appropri- 34. Lawson PJ, Flocke SA, Casucci B. De-
ate use of biologics in severe asth- velopment of an instrument to docu-
ma: Survey results. PLoS ONE. 2021 ment the 5A’s for smoking cessation. Am
Jun 29;16(6):e0253468. https://doi. J Prev Med. 2009 Sep;37(3):248-54.
org/10.1371/journal.pone.0253468 35. Kuruvilla ME, Lee FE, Lee GB. Un-
derstanding Asthma Phenotypes, En-
26. Graduenz GS, Carneiro DP, Vieira RP. dotypes, and Mechanisms of Dis-
Trends in asthma mortality in the 0- ease. Clin Rev Allergy Immunol. 2019
to 4-year and 5- to 34-year age groups Apr;56(2):219-33.
in Brazil. J Bras Pneumol. 2017 Jan- 36. Maltby S, Gibson PG, Powell H, et al.
Feb;43(1):24-31. Omalizumab Treatment Response in a
Population With Severe Allergic Asth-
27. França EB, Passos VMA, Malta DC, ma and Overlapping COPD. Chest.
et al. Cause-specific mortality for 249 2017 Jan;151(1):78-89.
causes in Brazil and states during 1990- 37. de Groot JC, Storm H, Amelink M,
2015: a systematic analysis for the glob- et al. Clinical profile of patients with
al burden of disease study 2015. Popul adult-onset eosinophilic asthma. ERJ
Health Metr. 2017 Nov 22;15(1):39. doi: Open Res. 2016;2(2):00100-2015. doi:
10.1186/s12963-017-0156-y. 10.1183/23120541.00100-2015.
38. Gibson PG, Yang IA, Upham JW, et
28. Fowles J, Dybing E. Application of al. Effect of azithromycin on asth-
toxicological risk assessment princi- ma exacerbations and quality of life in
ples to the chemical constituents of adults with persistent uncontrolled asth-
cigarette smoke. Tob Control. 2003 ma(AMAZES): a randomised, dou-
Dec;12(4):424-30. ble-blind, placebo-controlled trial. Lan-
cet. 2017 Aug 12;390(10095):659-68.
29. Kim SY, Sim S, Choi HG. Active, pas- 39. Culic O, Erakovic V, Parnham MJ. An-
sive, and electronic cigarette smoking is ti-inflammatory effects of macrolide an-
associated with asthma in adolescents. tibiotics. Eur J Pharmacol. 2001 Oct
Sci Rep. 2017 Dec 19;7(1):17789. doi: 19;429(1-3):209-29.
10.1038/s41598-017-17958-y. 40. Eguiluz-Gracia I, Tay TR, Hew M, et
al. Recent developments and highlights
30. Mlinarić A, Popović-Grle S, Nadalin in biomarkers in allergic disease and
S, et al. Passive smoking and respirato- asthma. Allergy. 2018 Dec;73(12):2290-
ry allergies in adolescents. Eur Rev Med 305.
Pharmacol Sci. 2011 Aug;15(8):973-7. 41. Rogliani P, Ora J, Puxeddu E, et al.
Airflow obstruction: is it asthma or is it
31. Strzelak A, Ratajczak A, Adamiec A, et COPD? Int J COPD. 2016;11(1):3007-
al. Tobacco Smoke Induces and Alters 13.
Immune Responses in the Lung Trig- 42. Lee JH, Haselkorn T, Borish L, et al.
gering Inflammation, Allergy, Asth- Risk factors associated with persis-
ma and Other Lung Diseases: A Mech- tent airflow limitation in severe or dif-
anistic Review. Int J Environ Res Public ficult-to-treat asthma: insights from
Health. 2018 May 21;15(5):1033. doi:
10.3390/ijerph15051033.
32. Comhair SA, Gaston BM, Ricci KS, et
al. Detrimental effects of environmen-
tal tobacco smoke in relation to asth-
ma severity. PLoS One. 2011 May
jarić Cincar S, et al. Attitudes of Cro- pone.0018574.
atian pulmonologists concerning ob- 33. https://www.euro.who.int/en controversies and dilemmas in severe asthma
stacles to earlier, more appropri- 34. Lawson PJ, Flocke SA, Casucci B. De-
ate use of biologics in severe asth- velopment of an instrument to docu-
ma: Survey results. PLoS ONE. 2021 ment the 5A’s for smoking cessation. Am
Jun 29;16(6):e0253468. https://doi. J Prev Med. 2009 Sep;37(3):248-54.
org/10.1371/journal.pone.0253468 35. Kuruvilla ME, Lee FE, Lee GB. Un-
derstanding Asthma Phenotypes, En-
26. Graduenz GS, Carneiro DP, Vieira RP. dotypes, and Mechanisms of Dis-
Trends in asthma mortality in the 0- ease. Clin Rev Allergy Immunol. 2019
to 4-year and 5- to 34-year age groups Apr;56(2):219-33.
in Brazil. J Bras Pneumol. 2017 Jan- 36. Maltby S, Gibson PG, Powell H, et al.
Feb;43(1):24-31. Omalizumab Treatment Response in a
Population With Severe Allergic Asth-
27. França EB, Passos VMA, Malta DC, ma and Overlapping COPD. Chest.
et al. Cause-specific mortality for 249 2017 Jan;151(1):78-89.
causes in Brazil and states during 1990- 37. de Groot JC, Storm H, Amelink M,
2015: a systematic analysis for the glob- et al. Clinical profile of patients with
al burden of disease study 2015. Popul adult-onset eosinophilic asthma. ERJ
Health Metr. 2017 Nov 22;15(1):39. doi: Open Res. 2016;2(2):00100-2015. doi:
10.1186/s12963-017-0156-y. 10.1183/23120541.00100-2015.
38. Gibson PG, Yang IA, Upham JW, et
28. Fowles J, Dybing E. Application of al. Effect of azithromycin on asth-
toxicological risk assessment princi- ma exacerbations and quality of life in
ples to the chemical constituents of adults with persistent uncontrolled asth-
cigarette smoke. Tob Control. 2003 ma(AMAZES): a randomised, dou-
Dec;12(4):424-30. ble-blind, placebo-controlled trial. Lan-
cet. 2017 Aug 12;390(10095):659-68.
29. Kim SY, Sim S, Choi HG. Active, pas- 39. Culic O, Erakovic V, Parnham MJ. An-
sive, and electronic cigarette smoking is ti-inflammatory effects of macrolide an-
associated with asthma in adolescents. tibiotics. Eur J Pharmacol. 2001 Oct
Sci Rep. 2017 Dec 19;7(1):17789. doi: 19;429(1-3):209-29.
10.1038/s41598-017-17958-y. 40. Eguiluz-Gracia I, Tay TR, Hew M, et
al. Recent developments and highlights
30. Mlinarić A, Popović-Grle S, Nadalin in biomarkers in allergic disease and
S, et al. Passive smoking and respirato- asthma. Allergy. 2018 Dec;73(12):2290-
ry allergies in adolescents. Eur Rev Med 305.
Pharmacol Sci. 2011 Aug;15(8):973-7. 41. Rogliani P, Ora J, Puxeddu E, et al.
Airflow obstruction: is it asthma or is it
31. Strzelak A, Ratajczak A, Adamiec A, et COPD? Int J COPD. 2016;11(1):3007-
al. Tobacco Smoke Induces and Alters 13.
Immune Responses in the Lung Trig- 42. Lee JH, Haselkorn T, Borish L, et al.
gering Inflammation, Allergy, Asth- Risk factors associated with persis-
ma and Other Lung Diseases: A Mech- tent airflow limitation in severe or dif-
anistic Review. Int J Environ Res Public ficult-to-treat asthma: insights from
Health. 2018 May 21;15(5):1033. doi:
10.3390/ijerph15051033.
32. Comhair SA, Gaston BM, Ricci KS, et
al. Detrimental effects of environmen-
tal tobacco smoke in relation to asth-
ma severity. PLoS One. 2011 May
